- Home
- RCUS vs VINP Comparison
RCUS vs VINP Comparison
Compare RCUS & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- VINP
- Stock Information
- Founded
- RCUS 2015
- VINP 2009
- Country
- RCUS United States
- VINP Brazil
- Employees
- RCUS N/A
- VINP N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- RCUS Health Care
- VINP Finance
- Exchange
- RCUS Nasdaq
- VINP Nasdaq
- Market Cap
- RCUS 727.1M
- VINP 616.8M
- IPO Year
- RCUS 2018
- VINP 2021
- Fundamental
- Price
- RCUS $8.28
- VINP $10.09
- Analyst Decision
- RCUS Buy
- VINP Strong Buy
- Analyst Count
- RCUS 11
- VINP 2
- Target Price
- RCUS $25.33
- VINP $13.25
- AVG Volume (30 Days)
- RCUS 1.2M
- VINP 61.5K
- Earning Date
- RCUS 05-06-2025
- VINP 05-12-2025
- Dividend Yield
- RCUS N/A
- VINP 6.44%
- EPS Growth
- RCUS N/A
- VINP N/A
- EPS
- RCUS N/A
- VINP 0.34
- Revenue
- RCUS $141,000,000.00
- VINP $97,136,413.00
- Revenue This Year
- RCUS N/A
- VINP $27.12
- Revenue Next Year
- RCUS $25.77
- VINP $16.70
- P/E Ratio
- RCUS N/A
- VINP $30.00
- Revenue Growth
- RCUS N/A
- VINP 32.21
- 52 Week Low
- RCUS $6.50
- VINP $8.66
- 52 Week High
- RCUS $18.98
- VINP $11.62
- Technical
- Relative Strength Index (RSI)
- RCUS 48.63
- VINP 61.88
- Support Level
- RCUS $7.06
- VINP $9.56
- Resistance Level
- RCUS $9.35
- VINP $9.89
- Average True Range (ATR)
- RCUS 0.55
- VINP 0.28
- MACD
- RCUS 0.06
- VINP 0.07
- Stochastic Oscillator
- RCUS 53.28
- VINP 96.15
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.